Market Overview

UPDATE: Credit Suisse Reinstates WellPoint with Neutral Rating, $65 PT

Related WLP
Does Anthem Want Cigna For $175/Share? Some Investors Are Buying Into The Rumor
The 'Hateful' Eight: 8 Stocks Institutional Investors Dumped Last Quarter

In a report published Wednesday, Credit Suisse Group reinstated coverage on WellPoint (NYSE: WLP) with a Neutral rating and $65.00 price target.

Credit Suisse noted, “WLP is one of the largest managed care companies in the U.S., and recently enhanced its diversification through its acquisition of Amerigroup. We believe the Blue Cross Blue Shield brand differentiates the company from peers, and positions the company well to capitalize on exchanges over time. However, the overhang and uncertainty of reform, particularly in 2014, when the company will have to defend its current individual and small group (ISG) business and potentially face margin pressure, keeps us on the sidelines.”

WellPoint closed on Monday at $60.92.

Latest Ratings for WLP

Nov 2014Bank of AmericaMaintainsBuy
Nov 2014UBSMaintainsBuy
Oct 2014JefferiesMaintainsBuy

View More Analyst Ratings for WLP
View the Latest Analyst Ratings

Posted-In: Credit Suisse GroupAnalyst Color Initiation Analyst Ratings


Related Articles (WLP)

View Comments and Join the Discussion!